Literature DB >> 16365422

Molecular, cellular, and antigen requirements for development of age-associated T cell clonal expansions in vivo.

Ilhem Messaoudi1, Jessica Warner, Dragana Nikolich-Zugich, Miranda Fischer, Janko Nikolich-Zugich.   

Abstract

T cell aging manifests itself both at the cellular (cell-autonomous defects in signaling) and at the population (age-related dysregulation of T cell homeostasis) levels. A prominent contributor to the latter is the appearance of T cell clonal expansions (TCE), with a potential to impair immune defense. In this study, we investigated molecular, cellular, and Ag requirements for TCE development. Of the mutant mice tested, old animals lacking MHC class I exhibited 7-fold fewer TCE than controls, with a 7-fold reduction in TCE. By contrast, animals lacking only one of the MHC class I molecules (Kb or Db), or IL-7R, or devoid of T cell renewal via adult thymectomy, all exhibited significant increases in TCE incidence. This increase directly correlated to lymphopenia, increased CD8 T cell turnover and an accumulation of memory-phenotype T cells. These data suggested that homeostatic cell division in the CD8 compartment enhances the formation of TCE. Repeated immunization with peptide/adjuvant did not result in an increase in Ag-specific TCE; however, adjuvant alone increased TCE incidence. In these experiments, therefore, nonspecific and/or homeostatic proliferation was more efficient in generating TCE in mice than repeated Ag-driven stimulation, suggesting that many, if not most, TCE in specific pathogen-free laboratory mice may be Ag-independent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16365422     DOI: 10.4049/jimmunol.176.1.301

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  CD8 T cell clonal expansions & aging: a heterogeneous phenomenon with a common outcome.

Authors:  Eric T Clambey; John W Kappler; Philippa Marrack
Journal:  Exp Gerontol       Date:  2007-01-02       Impact factor: 4.032

2.  Age-related dysregulation of CD8+ T cell memory specific for a persistent virus is independent of viral replication.

Authors:  Anna Lang; James D Brien; Ilhem Messaoudi; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

Review 3.  Nonhuman primate models of human immunology.

Authors:  Ilhem Messaoudi; Ryan Estep; Bridget Robinson; Scott W Wong
Journal:  Antioxid Redox Signal       Date:  2010-08-30       Impact factor: 8.401

4.  CD4+CD25+Foxp3+ regulatory T cells optimize diversity of the conventional T cell repertoire during reconstitution from lymphopenia.

Authors:  Colleen J Winstead; Cavan S Reilly; James J Moon; Marc K Jenkins; Sara E Hamilton; Stephen C Jameson; Sing Sing Way; Alexander Khoruts
Journal:  J Immunol       Date:  2010-03-31       Impact factor: 5.422

Review 5.  T-cell biology in aging, with a focus on lung disease.

Authors:  Naeun Lee; Min Sun Shin; Insoo Kang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

Review 6.  The narrowing of the CD8 T cell repertoire in old age.

Authors:  Marcia A Blackman; David L Woodland
Journal:  Curr Opin Immunol       Date:  2011-06-07       Impact factor: 7.486

Review 7.  [Aggressive primary cutaneous B-cell lymphomas and novel EBV+ entities].

Authors:  C Lamos; E Dippel
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 8.  Immune aging and autoimmunity.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Cell Mol Life Sci       Date:  2012-04-01       Impact factor: 9.261

Review 9.  Translational research in immune senescence: assessing the relevance of current models.

Authors:  Kevin P High; Arne N Akbar; Janko Nikolich-Zugich
Journal:  Semin Immunol       Date:  2012-05-23       Impact factor: 11.130

10.  Inflation and long-term maintenance of CD8 T cells responding to a latent herpesvirus depend upon establishment of latency and presence of viral antigens.

Authors:  Anna Lang; James D Brien; Janko Nikolich-Zugich
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.